Evidence map›Paper›PMID 33483926›Full record

ArticleEnvironmental science and pollution research international2021

Antioxidant properties of dietary supplements of free and nanoencapsulated silymarin and their ameliorative effects on silver nanoparticles induced oxidative stress in Nile tilapia (Oreochromis niloticus).

Shakila Veisi, Seyed Ali Johari, Charles R Tyler, Borhan Mansouri, Milad Esmaeilbeigi

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Milk Thistle (Current medicinal chemistry · 2025
    Review
  6. Article
  7. Article
  8. Nano-Nutraceuticals for Health: Principles and Applications.Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2023
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shakila VeisiDepartment of Fisheries, Faculty of Natural Resources, University of Kurdistan, Sanandaj, Iran.
Seyed Ali JohariDepartment of Fisheries, Faculty of Natural Resources, University of Kurdistan, Sanandaj, Iran. a.johari@uok.ac.ir.ORCID http://orcid.org/0000-0002-1210-5454
Charles R TylerBiosciences, College of Life and Environmental Sciences, University of Exeter, Geoffrey Pope, Stocker Road, Exeter, Devon, EX4 4QD, UK.
Borhan MansouriSubstance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. borhanmansouri@yahoo.com.
Milad EsmaeilbeigiDepartment of Marine Sciences, Tarbiat Modares University, Noor, Mazandaran, Iran.

Funding

University of Kurdistan GRC98-06503-1
6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) are increasingly used in a wide range of products and as a consequence, the environmental concentration will inevitably increase in the near future. Many aquatic organisms have been shown to be sensitive to the toxic effects of silver, including oxidative stress mechanisms. In this study, we assessed the ability of silymarin (Silybum marianum) to counter the oxidative effects of AgNPs in Nile tilapia (Oreochromis niloticus). Fish were fed on the diets supplemented with 50 or 200 mg kg

Indexed as

CichlidsMetal NanoparticlesSilymarinAnimalsAntioxidantsDietDietary SupplementsOxidative StressSilverAntioxidantsSilverSilymarinAntioxidant capacityFishLiverNanomicellesNanotechnologySilybum marianum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.